Australia’s AMP holds back dividend, to review policy post unit demerger

FAN Editor
FILE PHOTO: The logo of AMP Ltd, Australia's biggest retail wealth manager, adorns their head office located in central Sydney, Australia
FILE PHOTO: The logo of AMP Ltd, Australia’s biggest retail wealth manager, adorns their head office located in central Sydney, Australia, May 5, 2017. REUTERS/David Gray

August 11, 2021

(Reuters) -Australian wealth manager AMP Ltd posted a 57% jump in first-half underlying profit on Thursday, helped by stronger AMP Bank earnings and investment income from Group Office division, and held back on its interim dividend.

AMP said it would review the payment of dividends, as well as its capital management strategy, after completing the demerger of AMP Capital’s Private Markets business, slated in the first half of 2022.

The company has been trying to repair its reputation since 2018, when a public financial sector inquiry exposed systemic wrongdoing, including charging customers for services it did not provide and misleading regulators.

The embattled wealth manager added it was on-track to deliver A$300 million ($221.22 million) of annual run-rate cost savings by fiscal 2022.

“Getting our demerger done will be a core priority. We’ve set out a clear timeline to establish and separate the AMP Capital Private Markets business this year,” Chief Executive Officer Alexis George said in a statement.

Underlying net profit after tax from retained businesses was A$181 million for the half-year, while the company’s Australian wealth-management unit reported net cash outflows of A$2.7 billion, down from the A$4 billion reported last year.

($1 = 1.3569 Australian dollars)

(Reporting by Soumyajit Saha and Arundhati Dutta in Bengaluru; Editing by Shailesh Kuber)

Free America Network Articles

Leave a Reply

Next Post

FDA poised to authorize 3rd vaccine dose for immune-compromised people: Sources

The Food and Drug Administration is planning to authorize a third shot for the immune-compromised on Thursday, two sources familiar with the plans confirmed to ABC News. If the FDA green-lights the additional shots — first reported by NBC News — it’s up to the Advisory Committee on Immunization Practices, […]